Did You Know...
...that Charles Goodyear performed some of his experiments on rubber while in debtor's prison? He was there so often he referred to it as his "hotel". Chronically in debt because of poor business sense and ill health, Goodyear depended on the generosity of friends and family. Even after he unlocked the secret to vulcanizing rubber, he was unable to improve his financial situation. When he died, his estate was $200,000 in debt.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7214256 | Solvent extraction process A circuit configuration for a metal solvent extraction plant comprising: A) an extraction section for extracting metal ions from an aqueous leach solution containing the metal ions with an organic solvent solution containing at lea... | 05/08/2007 |
| 7208144 | Stabilized dispersion of behenyl alcohol IR 6 (Cosmetics, Toiletry and Fragrance Association, Inc., 7th ed. 1997). Viscosities are measured using Brookfield viscometers (1,000–20,000 cps, Spindle No. 5, 20 rpm, 60 second run, 25 degrees C.) unless otherwise indicated. 967-00—IR # 6961-00-1-A... | 04/24/2007 |
| 7176171 | Low-viscosity opacifiers without anionic surface-active agents An emulsifier mixture for use in a wax-based opacifier composition is comprised of: (a) an alkyl and/or alkenyl oligoglycoside; (b) a fatty acid partial glyceride and optionally (c) at least one amphoteric surfactant, with the proviso that the ratio by weight of (a)... | 02/13/2007 |
| 7166144 | Interlaced series parallel configuration for metal solvent extraction plants An interlaced series parallel configuration for the extraction of metal values from an metal value containing aqueous is a special series parallel configuration wherein the stripped organic is first contacted in a second extraction stage with the partially copper de... | 01/23/2007 |
| 7145023 | Processes for preparing solid tocopherol succinate calcium and magnesium salts Processes for preparing salts of alcohol polybasic acid partial esters are described wherein an alcohol polybasic acid partial ester is reacted with a compound selected from the group consisting of metal oxides, metal hydroxides, metal carbonates and mixtures thereo... | 12/05/2006 |
| 7138532 | Color-stable, low impurity tocopherol compositions and processes for preparing the same Processes for preparing color-stable, low-impurity tocopherol compositions are described, wherein the processes comprise: (a) providing a protecting group-substituted tocopherol compound, for example an acetate of a natural-source tocopherol compound; (b) purifying ... | 11/21/2006 |
| 7087570 | Detergent tablets Detergent tablets comprising surfactant granules obtained by granulation and compaction of a nonionic surfactant, selected from the group consisting of hydroxy mixed ethers, in the presence of a disintegrant, are described. ... | 08/08/2006 |
| 7083780 | Cosmetic composition containing hydroxyethers The use of hydroxyethers obtainable by ring opening of olefinic oxides having 6 to 18 carbon atoms with alcohols having 1 to 18 carbon atoms andlor polyols having 2 to 18 carbon atoms and 2 to 10 hydroxyl groups or water are proposed as oil bodies in cosmetic and/or... | 08/01/2006 |
| 7071343 | Method for producing epoxidated glyceride acetates Epoxidized glyceride acetates are made by a process which comprises reacting an epoxy fatty acid ester and triacetin. ... | 07/04/2006 |
| 7045494 | Alkyl and/or alkenyloligoglycoside preparations having reduced magnesium salt concentrations A process for making an alkyl and/or alkenyl oligoglycoside preparation having a magnesium salt concentration of less than about 10 ppm involving the steps of: (a) providing an alkyl and/or alkenyl oligoglycoside preparation having an active substance content of fro... | 05/16/2006 |
| 7026435 | Water-dispersible, hydrophobic polyalkyleneimine polyamide fiberglass lubricant, process for producing the same, and method of use therefor Polymer derivatives based upon polyalkyleneimine backbones having from about 20% to about 60% of their reactive amino functionalities substituted by C14-20 carboxylic acids, are disclosed. Fiber lubricants and/or sizing compositions comprising such polyme... | 04/11/2006 |
| 7017490 | Lithographic fountain solutions Lithographic fountain solutions containing a surfactant-effective quantity of at least one reaction product comprising the following reactants: (A) at least one compound of formula I R1(X)3 (I) wherein each X group is ... | 03/28/2006 |
| 6979467 | Microcapsules IV A microcapsule having a mean diameter of from about 0.1 to about 5 mm, a membrane and a matrix containing at least one active principle wherein the microcapsule is the product of the process comprising the steps of (a) forming an aqueous matrix by heating an aqueous... | 12/27/2005 |
| 6960304 | Wastewater treatment Methods for treating wastewater comprising adding to wastewater a defoaming and/or surfactant-effective quantity of at least one base-catalyzed branched reaction product comprising the following reactants: A) at least one compound ... | 11/01/2005 |
| 6936581 | Processes for preparing anhydrous detergent granules Processes are described for preparing anhydrous detergent granules, wherein the processes comprise: (a) providing an alk(en)yl oligoglycoside composition having a residual fatty alcohol content; (b) reducing the fatty alcohol content of the composition to 30% by wei... | 08/30/2005 |
| 6927240 | Granular solid with monodisperse particle size distribution A process for making granular solids involving: (a) providing a substantially anhydrous preparation, which is solid at room temperature and contain at least one cosmetic feed material; (b) liquifying the substantially anhydrous preparation to form a melt; (c) provid... | 08/09/2005 |
| 6919305 | Solid detergent compositions and methods of preparing the same Solid laundry detergents, dishwashing detergents and cleaners which are obtained by mixing gemini surfactants of the formula (I), R1CH(OH)CHR3(OCH2CH2)nOCHR4CH(OH)R2 (I) ... | 07/19/2005 |
| 6911164 | Spherical sterol preparations, their production and their use A process for making spherically-shaped sterol preparations involving: (a) providing a liquid sterol preparation; (b) forming the liquid sterol preparation into liquid sterol droplets; and (c) solidifying the liquid sterol droplets to form the spherically-shaped ste... | 06/28/2005 |
| 6638740 | Process of high purity albumin production The present invention relates to a process for purifying the protein human serum albumin extracted from serum or recombinant human albumin produced by transforming a microorganism with a nucleotide coding sequence encoding the amino acid sequence of human... | 10/28/2003 |
| 6613865 | Thermoplastic desiccant The invention relates to thermoplastic compositions that contain reactive isocyanate groups and that are suitable for use as desiccants for packaging moisture-sensitive goods, especially for polyurethane hotmelt adhesives that are cross-linked upon exposu... | 09/02/2003 |
| 5965696 | Potassium channel modulators This invention concerns peptides (I) having intracellular potassium channel modulating activity comprising the amino acid sequence shown in SEQ ID No: 2: (N terminal function) (I) Met Ile Ser Ser Val Cys Val Ser Ser 1 5... | 10/12/1999 |
| 5830909 | Angiotensin (AII) antagonists as inhibitors of the growth of adipose tissue The invention is a method of using Angiotensin (AII) Antagonists as inhibitors of the growth of adipose tissue, reducing adipocyte growth and body weight gain.... | 11/03/1998 |
| 5827847 | Treatment of cognitive disorders with piperazine derivatives Piperazine derivatives of formula (I) are useful in the treatment of cognitive disorders. In formula (I), X is a group of (IIa): --(CH2)n CR2 R3 CONR4 R5 or (IIIb): --A--NR6 COR | 10/27/1998 |
| 5763460 | N-(piperidinyl-1-alkyl)-substituted cyclohexane carboxylic acid amides as 5-htia receptor antagonists Compounds of formula (I) and the pharmaceutically acceptable acid addition salts thereof are 5-HT1A binding agents and may be used, for example, as anxiolytics. In the formula a and b each represents 0, 1, 2 or 3 such that the sum of a+b is 0, ... | 06/09/1998 |
| 5760220 | Process for preparation of biphenyl derivatives A process is described for preparing a compound of the formula I: ##STR1## or a salt thereof; wherein X is a protecting group and R1, R2, R3 and R4 are each independently hydrogen, C1-6 alkyl or ... | 06/02/1998 |
| 5714607 | Process improvement in the synthesis of N-3-(3-cyano-pyrazolo1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide The invention is a process improvement for producing N-3-(3-cyano-pyrazolo1,5-a!pyrimidin-7-yl)phenyl!-N-ethyl-acetamide which is useful as an anxiolytic, antiepileptic, sedative-hypnotic agent and skeletal muscle relaxant. The disclosed invention com... | 02/03/1998 |
| 5710149 | Piperazine derivatives as 5-ht antagonists This invention concerns compounds of formula (I) ##STR1## where A is a C1 or C2 alkylene chain optionally substituted by lower alkyl; Z is a bicyclic oxygen-containing aryl radical (e.g. 2,3-dihydro-1,4-benzodioxin-5-yl); R is h... | 01/20/1998 |
| 5637701 | Process for preparing optically active amide derivatives A novel asymmetric synthesis is provided for preparing optically active amides of formula (A) and their salts. ##STR1## In the formula, X represent --N-- or --CH--, R represents a mono or bicyclic aryl or heteroaryl group, R1 is an aryl or... | 06/10/1997 |
| 5629432 | Preparation of -aryl γ-butyrolactones This appliciation discloses a process for preparing a lactone of general formula (I), where R is an optionally substituted phenyl group or an optionally substituted mono- or bicyclic heteroaryl radical which process comprises reacting an anion of a malona... | 05/13/1997 |
| 5616588 | Rapamycin formulation for IV injection Disclosed herein is an aqueous, injectable rapamycin solution comprising 40 to 75 volume percent of a concentrate solution of rapamycin in propylene glycol, at concentrations of rapamycin ranging from 0.25 mg/ml to 8 mg/ml, in combination with a diluent s... | 04/01/1997 |
| 5610154 | Bicyclic carboxamides Bicyclic carboxamides of formula I ##STR1## and the pharmaceutically acceptable acid addition salts are 5-HT1A binding agents, particularly 5-HT1A antagonists and may be used, for example, as anxiolytics. In the formula X repres... | 03/11/1997 |
| 5601860 | Corandomized fat compositions for infant formulas The invention disclosed herein comprises fat compositions primarily for use in nutritionally complete infant formulas in which the constituent palmitic acid oils and lauric acid oils are corandomized. The invention additionally includes such corandomized ... | 02/11/1997 |
| 5585374 | Amide derivatives Amide derivatives of formula (I) and their pharmaceutically acceptable salts (where a and b each represent 0, 1, 2 or 3 such that a+b=0, 1, 2 or 3, the dotted line represents an optional double bond, A is an optionally substituted C1-2 -alkylen... | 12/17/1996 |
| 5541326 | Piperazine Derivatives Piperazine derivatives of formula: ##STR1## and their pharmaceutically acceptable acid addition salts are disclosed. In the formula, n is 1 or 2; R and R5 are hydrogen or lower alkyl, R1 is substituted or unsubstituted aryl or a... | 07/30/1996 |
| 5538956 | Amine derivatives containing a phosphonic acid moiety This invention concerns compounds of formula (I) wherein E represents hydrogen, C1 -C6 alkyl or a group Ar1 -A1 ; Ar and Ar1 when present each represent an aryl group of 6 to 10 carbon atoms or a hete... | 07/23/1996 |
| 5530006 | Rapamycin formulation for IV injection Disclosed herein is an aqueous, injectable rapamycin solution comprising 0.1 to 10 percent of a concentrate solution of rapamycin in N,N-dimethylacetamide, at concentrations of rapamycin ranging from 0.25 mg/ml to 100 mg/ml, in combination with a diluent ... | 06/25/1996 |
| 5527955 | Method of treating depression and tri-substituted amines therefor The invention concerns a method for treating depression or senile dementia using a compound which acts selectively as an agonist of gamma aminobutyric acid (GABA) at GABA autoreceptors with the proviso that the compound is not fengabine and progabide.... | 06/18/1996 |
| 5516770 | Rapamycin formulation for IV injection Disclosed herein is an aqueous, injectable rapamycin solution, obtained by a process consisting of mixing 5 to 30 volume percent of a concentrate solution of rapamycin in propylene glycol, at concentrations of rapamycin ranging from 0.5 mg/ml to 10 mg/ml,... | 05/14/1996 |
| 5502191 | Method of synthesizing sterically hindered 5-substituted-1H-tetrazoles from nitriles using a lewis acid and an azide A method for making 5-substituted tetrazoles of formula I: ##STR1## where R is as herein described which comprises reacting a compound of the formula R--CN with a Lewis acid and an azide or a preformed metal azide complex, acidifying and recovering t... | 03/26/1996 |
| 5498776 | Substituted pyrrolopyrimidines and pyridopyrimidines useful as angiotensin II antagonists This invention relates to pyrrolo-, pyrido-, azepino-, and azocinopyrimidines of the general formula I ##STR1## wherein R1, R2, R3, and R4 are independently H, lower alkyl containing 1 to 6 carbon atoms, or... | 03/12/1996 |
